Kyverna Therapeutics, Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KYTX and other ETFs, options, and stocks.

About KYTX

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

CEO

Warner Biddle

CEOWarner Biddle

Employees

112

Employees112

Headquarters

Emeryville, California

HeadquartersEmeryville, California

Founded

2018

Founded2018

Employees

112

Employees112

KYTX Key Statistics

Market cap

91.19M

Market cap91.19M

Price-Earnings ratio

-0.61

Price-Earnings ratio-0.61

Dividend yield

—

Dividend yield—

Average volume

240.31K

Average volume240.31K

High today

$2.17

High today$2.17

Low today

$2.07

Low today$2.07

Open price

$2.11

Open price$2.11

Volume

145.60K

Volume145.60K

52 Week high

$17.55

52 Week high$17.55

52 Week low

$1.78

52 Week low$1.78

Kyverna Therapeutics, Inc.

Why Robinhood?

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA. Show more

KYTX Key Statistics

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.